Editor's Note Healthcare providers could experience significant cash flow and operational changes under a new voluntary pilot program that fundamentally alters how the nation's second-largest drug payment program operates, according to an August 11 article in Modern Healthcare. As detailed in the article, The Health Resources and Services Administration announced…
Editor's Note The federal 340B Drug Pricing Program may soon shift from the Health Resources and Services Administration (HRSA) to the Centers for Medicare and Medicaid Services (CMS), a move that could bring tighter oversight and lasting consequences for safety-net providers, Modern Healthcare June 2 reports. The proposed transfer, part…